Minnesota implements universal newborn screening and surveillance for congenital cytomegalovirusMinnesota begins universal newborn screening for congenital cytomegalovirus

This publication is a 'Notes from the Field' surveillance report describing the implementation of universal newborn screening and population-based surveillance for congenital cytomegalovirus (cCMV) among newborns in Minnesota. The report outlines the program's structure but does not provide key operational details such as sample size, specific screening methods, or a defined comparator group.

No primary or secondary outcomes, follow-up duration, or results data are reported. The report does not include any findings on the program's effectiveness, detection rates, or clinical outcomes for identified infants. Safety and tolerability information, including adverse events or discontinuations, is also not reported.

Significant limitations include the absence of results data, making it impossible to assess the program's impact. The funding sources and potential conflicts of interest are not disclosed. As a descriptive field note without outcomes, this report serves only to document program initiation. Its practice relevance is limited to informing other jurisdictions considering similar surveillance infrastructure; it provides no evidence to guide clinical management of cCMV.